Drugmakers ask Supreme Court to restore abortion pill access by mail
The Washington Post • • nation
Key Points:
- The U.S. Court of Appeals for the 5th Circuit ruled that the abortion drug mifepristone must be picked up in person, limiting access through mail delivery.
- This ruling makes it more difficult for women to obtain the commonly used abortion pill.
- Two drug manufacturers, Danco Laboratories and GenBioPro, have filed emergency appeals to the Supreme Court seeking to allow continued access to mifepristone via mail.
- Danco Laboratories submitted the first appeal following the 5th Circuit's decision, with GenBioPro filing a similar request shortly after.
